# Open Label to Study to Evaluate Effect of Alfilbercept on Patients With (FVPED) Fibrovascular Pigment Epithelial Detachment

> **NCT01495208** · PHASE4 · WITHDRAWN · sponsor: **Vitreous -Retina- Macula Consultants of New York**

## Conditions studied

- Fibrovascular Pigment Epithelial Detachment

## Interventions

- **DRUG:** Aflibercept

## Key facts

- **NCT ID:** NCT01495208
- **Lead sponsor:** Vitreous -Retina- Macula Consultants of New York
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-12
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2018-07-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01495208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01495208, "Open Label to Study to Evaluate Effect of Alfilbercept on Patients With (FVPED) Fibrovascular Pigment Epithelial Detachment". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01495208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*